Noble Medichem Profile
Key Indicators
- Authorised Capital ₹ 5.14 Cr
- Paid Up Capital ₹ 2.49 Cr
- Company Age 32 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 38.08 Cr
- Satisfied Charges ₹ 12.02 Cr
- Revenue Growth 13.49%
- Profit Growth -39.73%
- Ebitda -21.65%
- Net Worth 22.89%
- Total Assets 20.53%
About Noble Medichem
Noble Medichem Private Limited (NMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 October 1992 and has a history of 32 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Manali Hill Resorts Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.14 Cr and a paid-up capital of Rs 2.49 Cr.
The company currently has active open charges totaling ₹38.08 Cr. The company has closed loans amounting to ₹12.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mihir Kapadia and Anuj Pandey serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100MH1992PTC069250
-
Company No.
069250
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Oct 1992
-
Date of AGM
28 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Noble Medichem Private Limited offer?
Noble Medichem Private Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Dettol Hand Sanitizer.
Who are the key members and board of directors at Noble Medichem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mihir Kapadia
|
Director | 29-Aug-2007 | Current |
|
Anuj Pandey
|
Director | 04-Dec-2018 | Current |
Financial Performance of Noble Medichem.
Noble Medichem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.49% increase. The company also saw a substantial fall in profitability, with a 39.73% decrease in profit. The company's net worth Soared by an impressive increase of 22.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noble Medichem?
In 2023, Noble Medichem had a public holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Noble Plus Online Private LimitedMihir Kapadia and Anuj Pandey are mutual person
-
Noble Medicals Private LimitedMihir Kapadia and Anuj Pandey are mutual person
-
Noble Essential Services Llp
Anuj Pandey is a mutual person
Charges (Loans)
₹38.08 Cr
₹12.02 Cr
Charges Breakdown by Lending Institutions
- Others : 28.99 Cr
- Standard Chartered Bank : 8.75 Cr
- Hdfc Bank Limited : 0.34 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2023 | Others | ₹1.29 Cr | Open |
| 22 Dec 2022 | Others | ₹6.00 Cr | Open |
| 26 Feb 2022 | Others | ₹17.20 Cr | Open |
| 24 Sep 2021 | Hdfc Bank Limited | ₹0.95 M | Open |
| 06 Sep 2021 | Hdfc Bank Limited | ₹2.44 M | Open |
How Many Employees Work at Noble Medichem?
Noble Medichem has a workforce of 186 employees as of Aug 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Medichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Medichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
